{"entity":{"type":"insider","cik":"0001510643","url":"/insider/0001510643","json_url":"/insider/0001510643.json","name":"A. van Herk Holding B.V.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":3,"first":"2018-02-27","last":"2019-02-25","span_basis":"filed_date"},"name_variants":[{"name":"A. van Herk Holding B.V.","source":"filing","n_filings":3,"first_seen":"2018-02-27","last_seen":"2019-02-25"}],"transactions":[{"id":7995290,"accession":"0001104659-19-010365","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-010365","line_url":"/filing/0001104659-19-010365#line-2","is_derivative":false,"issuer_cik":"0001441693","issuer_name":"MARRONE BIO INNOVATIONS INC","issuer_ticker":"MBII","issuer_name_source":null,"issuer_url":"/issuer/0001441693","owner_cik":null,"owner_name":"van Herk Adrianus; A. van Herk Holding B.V.; Van Herk Private Equity Investments B.V.; Van Herk Management Services B.V.; Stichting Administratiekantoor Penulata; Stichting Administratiekantoor Abchrys; VAN HERK INVESTMENTS B.V.; Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.","owner_display_name":"van Herk Adrianus","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500000.0,"shares_display":"1,500,000","price_per_share":1.57,"price_display":"1.57","price_state":"stated","total_value":2355000.0,"total_display":"2,355,000.00","total_whole":"2,355,000","shares_owned_after":5628770.0,"shares_owned_after_display":"5,628,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-21","filed_date":"2019-02-25","scope":"insider"},{"id":7995285,"accession":"0001104659-19-010365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-010365","line_url":"/filing/0001104659-19-010365#line-1","is_derivative":false,"issuer_cik":"0001441693","issuer_name":"MARRONE BIO INNOVATIONS INC","issuer_ticker":"MBII","issuer_name_source":null,"issuer_url":"/issuer/0001441693","owner_cik":null,"owner_name":"van Herk Adrianus; A. van Herk Holding B.V.; Van Herk Private Equity Investments B.V.; Van Herk Management Services B.V.; Stichting Administratiekantoor Penulata; Stichting Administratiekantoor Abchrys; VAN HERK INVESTMENTS B.V.; Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.","owner_display_name":"van Herk Adrianus","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":300.0,"total_display":"300.00","total_whole":"300","shares_owned_after":7128770.0,"shares_owned_after_display":"7,128,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-14","filed_date":"2019-02-25","scope":"insider"},{"id":5962039,"accession":"0001104659-18-062891","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-18-062891","line_url":"/filing/0001104659-18-062891#line-4","is_derivative":false,"issuer_cik":"0001441693","issuer_name":"MARRONE BIO INNOVATIONS INC","issuer_ticker":"MBII","issuer_name_source":null,"issuer_url":"/issuer/0001441693","owner_cik":null,"owner_name":"A. van Herk Holding B.V.; Stichting Administratiekantoor Penulata; Van Herk Management Services B.V.; Stichting Administratiekantoor Abchrys; Van Herk Private Equity Investments B.V.; Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.; VAN HERK INVESTMENTS B.V.; van Herk Adrianus","owner_display_name":"A. van Herk Holding B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":585.0,"total_display":"585.00","total_whole":"585","shares_owned_after":7126570.0,"shares_owned_after_display":"7,126,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-26","filed_date":"2018-10-19","scope":"insider"},{"id":5962036,"accession":"0001104659-18-062891","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-18-062891","line_url":"/filing/0001104659-18-062891#line-3","is_derivative":false,"issuer_cik":"0001441693","issuer_name":"MARRONE BIO INNOVATIONS INC","issuer_ticker":"MBII","issuer_name_source":null,"issuer_url":"/issuer/0001441693","owner_cik":null,"owner_name":"A. van Herk Holding B.V.; Stichting Administratiekantoor Penulata; Van Herk Management Services B.V.; Stichting Administratiekantoor Abchrys; Van Herk Private Equity Investments B.V.; Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.; VAN HERK INVESTMENTS B.V.; van Herk Adrianus","owner_display_name":"A. van Herk Holding B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":3800.0,"total_display":"3,800.00","total_whole":"3,800","shares_owned_after":7128570.0,"shares_owned_after_display":"7,128,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-26","filed_date":"2018-10-19","scope":"insider"},{"id":5962034,"accession":"0001104659-18-062891","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-062891","line_url":"/filing/0001104659-18-062891#line-2","is_derivative":false,"issuer_cik":"0001441693","issuer_name":"MARRONE BIO INNOVATIONS INC","issuer_ticker":"MBII","issuer_name_source":null,"issuer_url":"/issuer/0001441693","owner_cik":null,"owner_name":"A. van Herk Holding B.V.; Stichting Administratiekantoor Penulata; Van Herk Management Services B.V.; Stichting Administratiekantoor Abchrys; Van Herk Private Equity Investments B.V.; Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.; VAN HERK INVESTMENTS B.V.; van Herk Adrianus","owner_display_name":"A. van Herk Holding B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17078.0,"shares_display":"17,078","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":33472.88,"total_display":"33,472.88","total_whole":"33,473","shares_owned_after":7126870.0,"shares_owned_after_display":"7,126,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-25","filed_date":"2018-10-19","scope":"insider"},{"id":5962030,"accession":"0001104659-18-062891","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-062891","line_url":"/filing/0001104659-18-062891#line-1","is_derivative":false,"issuer_cik":"0001441693","issuer_name":"MARRONE BIO INNOVATIONS INC","issuer_ticker":"MBII","issuer_name_source":null,"issuer_url":"/issuer/0001441693","owner_cik":null,"owner_name":"A. van Herk Holding B.V.; Stichting Administratiekantoor Penulata; Van Herk Management Services B.V.; Stichting Administratiekantoor Abchrys; Van Herk Private Equity Investments B.V.; Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.; VAN HERK INVESTMENTS B.V.; van Herk Adrianus","owner_display_name":"A. van Herk Holding B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":390.0,"total_display":"390.00","total_whole":"390","shares_owned_after":7143948.0,"shares_owned_after_display":"7,143,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-24","filed_date":"2018-10-19","scope":"insider"},{"id":6602979,"accession":"0001104659-18-012889","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-18-012889","line_url":"/filing/0001104659-18-012889#line-3","is_derivative":false,"issuer_cik":"0001441693","issuer_name":"MARRONE BIO INNOVATIONS INC","issuer_ticker":"MBII","issuer_name_source":null,"issuer_url":"/issuer/0001441693","owner_cik":null,"owner_name":"Stichting Administratiekantoor Abchrys; van Herk Adrianus; Van Herk Private Equity Investments B.V.; Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.; Van Herk Management Services B.V.; A. van Herk Holding B.V.; VAN HERK INVESTMENTS B.V.; Stichting Administratiekantoor Penulata","owner_display_name":"Stichting Administratiekantoor Abchrys","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.23,"price_display":"1.23","price_state":"stated","total_value":6150.0,"total_display":"6,150.00","total_whole":"6,150","shares_owned_after":7139148.0,"shares_owned_after_display":"7,139,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-27","scope":"insider"},{"id":6602976,"accession":"0001104659-18-012889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-012889","line_url":"/filing/0001104659-18-012889","is_derivative":false,"issuer_cik":"0001441693","issuer_name":"MARRONE BIO INNOVATIONS INC","issuer_ticker":"MBII","issuer_name_source":null,"issuer_url":"/issuer/0001441693","owner_cik":null,"owner_name":"Stichting Administratiekantoor Abchrys; van Herk Adrianus; Van Herk Private Equity Investments B.V.; Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.; Van Herk Management Services B.V.; A. van Herk Holding B.V.; VAN HERK INVESTMENTS B.V.; Stichting Administratiekantoor Penulata","owner_display_name":"Stichting Administratiekantoor Abchrys","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.16288,"price_display":"1.16","price_state":"stated","total_value":5814.4,"total_display":"5,814.40","total_whole":"5,814","shares_owned_after":7142148.0,"shares_owned_after_display":"7,142,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-27","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001441693","name":"MARRONE BIO INNOVATIONS INC","url":"/issuer/0001441693","role":"Ten percent owner","n_filings":3,"first_seen":"2018-02-27","last_seen":"2019-02-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001510643","retrieved_at":"2026-08-22T23:00:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}